EUVIMEDEUVIMED entdecken
Crossref

Bioactive venetoclax-lipid nanomedicine enhances therapeutic efficacy in acute myeloid leukemia

Yishan Li, Yinglin Xu, Yijun Zhao, Tianqi Liu, Yixin Ma, Songqi Zhu, Chen Xie, Cheuk-Him Man, Kun Zhou

Journal of Materials Chemistry B · 2026 · 14 (31) · 9808-9816

DOI: 10.1039/d6tb01032f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2026. Verfasst von Yishan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080,…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Sulfonamides, Antineoplastic Agents, Bridged Bicyclo Compounds, Heterocyclic. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vene-lipo enhances anti-leukemic efficacy and prolongs survival in acute myeloid leukemia (AML) compared to free venetoclax.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteSulfonamidesAntineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicNanomedicineLipidsHumansAnimalsApoptosisCell ProliferationMiceDrug Screening Assays, Antitumor

Substanzen

SulfonamidesvenetoclaxAntineoplastic AgentsBridged Bicyclo Compounds, HeterocyclicLipids

Autor:innen und Institutionen

  • Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China. imyishanlee@gmail.com.
  • Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou 511400, China.
  • Key Laboratory of Stem Cells and Tissue Engineering (Ministry of Education), Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China. csman2021@yahoo.com.hk.
  • Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Xu, Y., Zhao, Y., Liu, T., Ma, Y., Zhu, S., Xie, C., Man, C. H., & Zhou, K. (2026). Bioactive venetoclax-lipid nanomedicine enhances therapeutic efficacy in acute myeloid leukemia. Journal of Materials Chemistry B, 14(31), 9808-9816. https://doi.org/10.1039/d6tb01032f

Vancouver

Li Y, Xu Y, Zhao Y, Liu T, Ma Y, Zhu S, et al. Bioactive venetoclax-lipid nanomedicine enhances therapeutic efficacy in acute myeloid leukemia. Journal of Materials Chemistry B. 2026;14(31):9808-9816. doi:10.1039/d6tb01032f

BibTeX
@article{Li2026,
  author = {Li, Yishan and Xu, Yinglin and Zhao, Yijun and Liu, Tianqi and Ma, Yixin and Zhu, Songqi and Xie, Chen and Man, Cheuk-Him and Zhou, Kun},
  title = {Bioactive venetoclax-lipid nanomedicine enhances therapeutic efficacy in acute myeloid leukemia},
  journal = {Journal of Materials Chemistry B},
  year = {2026},
  volume = {14},
  number = {31},
  pages = {9808--9816},
  doi = {10.1039/d6tb01032f}
}
Kostenlos starten →